Filing Details

Accession Number:
0001698450-17-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-08 16:53:36
Reporting Period:
2017-03-06
Filing Date:
2017-03-08
Accepted Time:
2017-03-08 16:53:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1433642 Hamilton Lane Inc HLNE Investment Advice (6282) 262482738
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1698040 Juan Delgado-Moreira C/o Hamilton Lane Incorporated
One Presidential Blvd., 4Th Floor
Bala Cynwyd PA 19004
Managing Director No Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2017-03-06 1,550,965 $0.00 1,550,965 No 4 J Direct
Class A Common Stock Acquisiton 2017-03-06 2,800 $16.00 1,553,765 No 4 P Direct
Restricted Class A Common Stock Acquisiton 2017-03-06 77,868 $0.00 1,628,833 No 4 J Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 P Direct
No 4 J Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Class A Common Stock Employee Stock Option (right to buy) Acquisiton 2017-03-06 233,495 $0.00 233,495 $1.34
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
233,495 2017-03-06 2017-06-01 No 4 J Direct
Footnotes
  1. In the reorganization (the "Reorganization") of Hamilton Lane Advisors, L.L.C. ("HLA") in connection with the Issuer's initial public offering (the "IPO"), the reporting person exchanged membership interests of HLA owned prior to the IPO for Class A Common Stock of the Issuer.
  2. Purchase of shares in Issuer's directed share program in connection with its initial public offering.
  3. Represents the number of shares issued to the reporting person pursuant to an award of restricted stock under the Issuer's 2017 Equity Incentive Plan. The award was issued in substitution for existing awards of restricted interests in HLA that were issued annually in the years prior to the IPO, and the new award vests according to the same vesting schedule as the replaced awards: in four equal annual installments each March. Accordingly, one tranche will vest in 2017, one in 2018, one in 2019 and one in 2020.
  4. These options were granted under the Issuer's 2017 Equity Incentive Plan in substitution for outstanding options to purchase non-voting interests of HLA that were issued in 2007, prior to the IPO. The options being replaced were fully vested, and so the substitute award is fully vested.